Clinical Trials Logo

ICU clinical trials

View clinical trials related to ICU.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03670017 Terminated - Dysglycemia Clinical Trials

Glucose Time-In-Range Development Evaluation

GIDE
Start date: September 6, 2018
Phase: N/A
Study type: Interventional

The study will evaluate patients requiring frequent glucose monitoring in a Surgical ICU. The study population includes surgical critical care patients who require blood glucose monitoring. Subjects must have a vascular access device [i.e., Central Venous Catheters (CVC), Multi-lumen Access Catheters (MAC) either in place or to be placed with an expected usage of at least 48 hours. During Phase One of the trial, patients will be connected to the OptiScanner for up to 72 hours and the hospital's current standard of care for glucose management will be followed.